| Prev Close | 183.73 |
| Day Low/High | 181.06 / 184.83 |
| 52 Wk Low/High | 150.37 / 233.00 |
| Avg Volume | 1.83M |
Constellation Brands Inc. (STZ)
181.26
NYSE : Consumer Non-Durables
| Exchange | NYSE |
| Shares Outstanding | 167.21M |
| Market Cap | 35.23B |
| EPS | 18.20 |
| P/E Ratio | 10.46 |
| Div & Yield | 3.00 (1.60%) |
How Are My Ideas Working Out? January Trade Review (Part 1)
Eight of these 11 trade ideas are in the green, with a few big winners.
SLANG Is the Cannabis IPO to Watch This Week
While consolidation may be key to the cannabis market in 2019, this IPO is worthy of a deeper dive.
Excuse Me, Would You Like Some Cannabis With Your Coffee?
CBD could make coffee an around the clock craze.
Chart of the Day, Part 2: A Closer Look at Constellation's Big Cannabis Bet
Canopy Growth's smoking engine won't necessarily ensure smooth sailing for Constellation.
Chart of the Day, Part 1: Canopy Growth Could Be Key to Constellation Long Term
Analysts have noted that the weed leader's momentum is set to burn higher moving forward.
How to Trade Constellation Brands Now Using Options
I'm strategizing a risk reversal here using a put sale to fund a long-side play.
Constellation Brands Benefits From Analyst Upgrades After Wednesday's Selloff
Even formerly bearish analysts are changing their tune as the risks appear to be fully baked in at this point.
Buyers Belly Up to Constellation Brands After Wednesday's Big Stumble
A number of analysts maintain the beer and wine giant's valuation is even more attractive for long-term investors thanks to a sharp decline in its shares.
Jim Cramer: Constellation Brands Continues to Look Intriguing
Even with its 12% stock decline on Wednesday, Constellation Brands is more intriguing than it was yesterday.
Constellation Brands Still Has a Lot to Prove
The company's third quarter was a mixed bag.
Paradise (Partially) Lost!
It's amazing how this business works. I launched my Canopy Growth Corp. analysis about three weeks ago in conjunction with my analysis of Constellation Brands (down by -$21/share today) -- as STZ had recently made the big investment in CGC. My concl...
Trade Resolution Would Keep This Correction From Becoming a Crash: Market Recon
Plus, a resolution of the government shut-down needs to happen soon.
Real Money Goes Behind the Scenes of the Budding Cannabis Industry
In the interest of due diligence, we went and took a close look at the ground floor of the newest investment craze.
Constellation Brands Could Satisfy Your Thirst for a Trade From the Long Side
Aggressive traders could probe the long side of STZ at current levels and on a shallow dip.
Who Hasn't Crashed the Cannabis Party Yet?
Establishing who the stragglers are and what impact they might have in the future is the key at this point.
Tilray Is Now a Top-Tier Cannabis Play
I'd be most interested in buying this name after a cap raise which I expect in the first quarter of 2019.
Chart of the Day, Part 2: Tilray's Deal is Tiny Compared to Canopy's
Perhaps no company has bought into the Canadian cannabis craze more than Constellation Brands.
Tilray Stock Burns Higher With Anheuser-Busch Beverage Deal
Pot stock partnerships are a gateway to gains for cannabis investors.
Here's Why I See Potential With Aphria
The stock is finally down to realistic levels.
Big Tobacco Hasn't Killed Cannabis, This Dance Has Only Just Begun
After Altria's investment in Cronos Group, which cannabis company will be the next target?
Constellation Brands Is Giving Us Subtle Clues That It Wants to Rally
Turns to the upside and downside can be subtle but it looks like Constellation Brands is giving us some subtle bullish clues.
Jim Cramer: What If Trump Tweets Xi Forced Him to Ignite the 25% Tariff Fuse?
Here are 4 stocks that can be bought into the stock cyclone that might occur if things don't go the bulls way in the Argentine.
Here's Why Tilray Stock Is the Wild Child
Perhaps the highest profile impact on Tilray equity performance has been the interest of Andrew Left of Citron Research.
Tilray Stock Higher Ahead of First Post-Legalization Earnings Release
Tilray will have a lot to tackle this evening.
Focus on FOMC After Rip-Roaring Day for Stocks: Market Recon
Consumer Discretionary stocks were the hottest on Wednesday, though all eleven sectors easily finished in the green.
What Barclays Gets Wrong About Cannabis and Tobacco
Cannabis and tobacco are hard to equate, which Barclays' primer on the Cannabis industry misses.
